Triciribine Phosphate

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameTriciribine Phosphate
Drug Alias Name曲西立滨Triciribinum曲西立滨磷酸酯TriciribineTriciribina +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitors
TargetsSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsHematologic NeoplasmsOvarian NeoplasmsBreast Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesPrescient Therapeutics Ltd
Inactive CompaniesNational Cancer Institute
Active IndicationsLeukemia
Inactive IndicationsHematologic NeoplasmsOvarian NeoplasmsBreast Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksKEGG